Farther Finance Advisors LLC Buys 713 Shares of DaVita Inc. (NYSE:DVA)

Farther Finance Advisors LLC grew its stake in shares of DaVita Inc. (NYSE:DVA) by 199.7% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 1,070 shares of the company’s stock after acquiring an additional 713 shares during the quarter. Farther Finance Advisors LLC’s holdings in DaVita were worth $163,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of DVA. Wellington Management Group LLP raised its stake in DaVita by 9.1% in the fourth quarter. Wellington Management Group LLP now owns 2,711 shares of the company’s stock valued at $405,000 after purchasing an additional 227 shares in the last quarter. Hussman Strategic Advisors Inc. increased its holdings in DaVita by 200.0% in the 4th quarter. Hussman Strategic Advisors Inc. now owns 25,200 shares of the company’s stock valued at $3,769,000 after buying an additional 16,800 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of DaVita in the 4th quarter valued at approximately $597,000. Proficio Capital Partners LLC bought a new stake in shares of DaVita during the 4th quarter worth approximately $5,636,000. Finally, SBI Securities Co. Ltd. bought a new stake in shares of DaVita during the 4th quarter worth approximately $41,000. 90.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have commented on DVA. Truist Financial lowered their price objective on shares of DaVita from $170.00 to $164.00 and set a “hold” rating for the company in a research report on Monday, May 19th. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. Finally, Wall Street Zen raised DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $164.50.

DaVita Stock Performance

Shares of DaVita stock opened at $135.65 on Friday. The company’s 50 day moving average price is $140.22 and its two-hundred day moving average price is $150.38. The firm has a market capitalization of $10.24 billion, a P/E ratio of 13.44, a P/E/G ratio of 0.94 and a beta of 1.11. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Monday, May 12th. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.25. The company had revenue of $3.22 billion during the quarter, compared to analysts’ expectations of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. DaVita’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.26 EPS. On average, equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.